Cysteinyl-leukotrienes are rapidly generated at sites of inflammation and, besides their role in asthma, rhinitis, and other immune disorders, are increasingly regarded as Interestingly, also G s -coupled receptors (β 2 AR, H 1/2 R EP 2/4 R) are able to desensitize
Introduction
Cysteinyl-leukotrienes (cysteinyl-LTs), i.e. LTC 4 , LTD 4 and LTE 4 are members of a large family of biologically active lipid mediators rapidly generated at sites of inflammation from arachidonic acid via the 5-lipoxygenase (5-LO) pathway (1) . They are synthesized by inflammatory cells, such as eosinophils, basophils, mast cells, and alveolar macrophages, in response to different immune and inflammatory stimuli (2) . Beyond their well recognized role in asthma and immune disorders, cysteinyl-LTs are increasingly regarded as significant inflammatory factors in cancer, gastrointestinal and cardiovascular diseases (3) . In the past few years, the use of LT receptor antagonists as cardiovascular drugs has become a matter of considerable interest (4) (5) (6) , as the presence of 5-LO, FLAP and LT receptors transcripts has been shown in atherosclerotic lesions at various stages of development in human aorta, coronary arteries, and carotid arteries (3) .
The effects of cysteinyl-LTs are mediated through two officially recognized receptor subtypes: CysLT 1 and CysLT 2 , (2, 3), which belong to the G-protein-coupled receptor (GPCR) gene superfamily and particularly to the purine receptor cluster (within the δ group) of the rhodopsin family (7) . Over the years, several data in the literature suggested the existence of additional CysLT receptor (CysLT-R) subtypes in humans (3) , and very recently new pharmacological targets have been identified for cysteinyl-LTs, i.e. two possible new receptor entities (8, 9 ) and a CysLT 1 /CysLT 2 heterodimer (10) .
The activation of a number of receptors does not always lead to a direct effect on a particular signaling pathway, but rather to amplification (11, 12) or, more often, to inhibition of the response produced by distinct but convergent signals (13) (14) (15) (16) . In by guest, on September 9, 2017 www.jlr.org Downloaded from this respect heterologous desensitization, i.e. the reduced response to activation of an unrelated or apparently unrelated receptor that have not been exposed to agonist, plays an important role (17, 18) . This latter process is generally ascribed to the action of different kinases, such as PKA and PKC that participate to a feedback mechanism in which the second messenger activates a kinase that, in turn, modulates the activity of other receptors.
Monocytes/macrophages, besides providing innate immune surveillance for every tissue in the body, are generally believed to sustain and precipitate pathological states. Cytokines, 5-LO metabolites and several other agents selectively home monocytes to the parenchymal tissue where they participate to the innate immune response and lipid hoemostasis (19) . Of particular interest is the ability of macrophages to produce large amounts of proinflammatory mediators including cytokines (20) , prostaglandins, and LTs (2) as well as to express inflammatory surface receptors such as CysLT 1 (3) . This correlates with the recent finding that cysteinylLTs might contribute to inflammatory reactions by induction of MCP-1 (21) , and increasing CCR2B expression in human monocytes/macrophages (22) .
The past decade have revealed that macrophage-derived foam cells are integral to the development and progression of atherosclerosis (23) , while a very recent paper demonstrate that montelukast (Singulair), a specific CysLT 1 R antagonist widely used for asthma treatment, prevented ROS production and reduces atherosclerotic plaque formation in apolipoprotein E-deficient knockout mice in vivo (24) . Finally, monocyte/macrophage lineage may play a potential role in the pathophysiology of COPD (25) as well in tumor initiation and various key steps in growth and metastasis (26 International.
Cell culture
U937 cells (ATCC) were routinely cultured into flasks in RPMI 1640 medium supplemented with 10% FBS, 2 mM L-glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin at 37C° (5% CO 2 ) and differentiated for 96 hrs with 1.3% dimethylsulphoxyde, as previously described (29) .
Isolation of primary human monocytes
Blood from healthy donors was collected into sodium citrate 3,8% or in citrate phosphate dextrose (CPD) and centrifuged at 200 x g for 15min. The heterologous desensitization protocol has been performed as previously described (16) . Briefly, the second challenge was dispensed 3 min after the first challenge, or when [Ca 2+ ] i levels have returned to baseline without washing the sample.
Statistical analysis
Statistical analysis of concentration-response curves was performed using GraphPad Prism version 4, which use the four parameters logistic model as described in the ALLFIT program (31 ] i ) in DMSO-differentiated U937 (dU937) cells through the activation of the CysLT 1 R promiscuously coupled to both G q and G i (16, 29, 30) . In the same cells, the ability to
] i is shared also by other inflammatory stimuli, through different molecular signaling pathways. Indeed, LTB 4 , fMLF, UTP and PAF were found to increase [Ca 2+ ] i through the activation of specific receptors exclusively coupled either to G q/11 (PAF-R) or G i (FPR1) or promiscuously coupled to both G proteins (BLT 1 R and P2Y 2/6 R) (Tab. 1). In addition, a number of other inflammatory or inflammatoryrelated stimuli, e.g. PGE 2 histamine and isoproterenol, were found to increase cAMP levels in dU937 cells through activation of their G s protein-coupled receptors (EP 2/4 R, H 1/2 R and β 2 AR, respectively) (Tab. 1). These heterogeneous stimuli were, therefore, studied to expand previous notion of extracellular nucleotides regulation of CysLT 1 R activity (16) , examining the possibility that they might participate in CysLT 1 R regulation through specific molecular mechanism and possibly specific hierarchical organization.
Effect of G i -coupled receptors on CysLT 1 R-induced [Ca 2+ ] i transient
We examined modulation of fMLF. Figure 1A shows the concentration-dependent desensitization curve of fMLF on the response elicited by 10 nM LTD 4 in dU937 cells. Maximum degree of desensitization (77%, p < 0.01) was obtained starting from 3 µM fMLF (Fig. 1A ).
This effect can be largely prevented by a 5 min pre-incubation with increasing concentration of the PKC inhibitor GFX (Fig. 1B 
Effect of a G q -coupled receptor on CysLT 1 -induced [Ca

2+ ] i transient
We also examined the possible effect of a "pure" G q/11 -coupled receptor, such as PAF-R, on the regulation of CysLT 1 R activity. Figure 2A shows that a first challenge with 36 nM PAF affected LTD 4 -induced response up to 35% (p < 0.01), and that this effect cannot be substantially prevented by increasing concentration of GFX.
In addition, neither pretreatment with 10 µM H89, a PKA inhibitor, nor with 10 µM KN93, a Ca 2+ /calmodulin-dependent kinase II (CaMKII) inhibitor, or with 10 µM KT-5823, a PKG inhibitor, alone or in addition to GFX, were able to completely revert PAF-induced CysLT 1 desensitization (data not shown).
Specificity of PAF response was assessed by demonstrating that 10 µM of the PAF-R antagonist WEB 2086 completely prevented PAF signal (data not shown) and PAF-induced CysLT 1 R desensitization (Fig. 2B) .
Effect of YM-254890 on PAF-induced CysLT 1 R heterologous desensitization
We previously reported that use of YM-254890 to selectively inhibit the G q signaling pathway, produced important augmentation of P2Y-induced CysLT 1 desensitization compared to untreated cells, suggesting that the majority of P2Y- Moreover, Figure 3A and B clearly demonstrate that after a first challenge with LTD 4 , cells can still be responsive to the second challenge with a different agonist, ruling out the possibility that the heterologous desensitization here observed might depend upon an altered ability of the cells to mobilize calcium.
Effect of isoproterenol challenge on CysLT 1 -induced [Ca 2+ ] i transient
As previously mentioned, dU937 cells express a number of receptors for inflammatory related stimuli that, at variance with the stimuli previously examined,
are not coupled to G q/11 or G i/o , but rather to G s (Tab. 1). Thus, to verify whether cAMP increase could affect LTD 4 -induced response through activation of PKA, we challenged dU937 cells with increasing concentrations of the β 2 AR agonist isoproterenol. Indeed, Figure 4A shows that isoproterenol dose-dependently impaired the CysLT 1 R response up to 70%, and that this effect can be only partially reverted by pretreatment of cells with 10 µM of the widely used PKA inhibitor H89 (53% recovery, p < 0.01) (Fig. 4B) . It is also clear from Figure 4B that while GFX at a concentration of 1 µM, i.e. a concentration at which the compound is specific for PKC, had no effect on the isoproterenol-induced CysLT 1 R desensitization, at 10 µM,
i.e. a concentration at which GFX start to inhibit also PKA (32), it had an effect similar to that of H89 induced desensitization of the CysLT 1 R up to 61% and 56%, respectively (p < 0.01, Fig. 5A and B). Again, both effects could only be partially reverted by 10 µM GFX or 10 µH89. Finally, similar to isoproterenol data, there was no effect of PTX pretreatment on PGE 2 and histamine-induced desensitization (data not shown).
Effect of forskolin pretreatment on CysLT 1 -induced [Ca 2+ ] i transient
To confirm cAMP-induced CysLT 1 transregulation, we investigated the effect of a non specific activator of adenylate cyclase. 100 µM forskolin completely desensitized the CysLT 1 R (Fig. 6) , confirming the involvement of cAMP in the regulation of the activity of the CysLT 1 R and strongly indicating that also the second messenger-activated PKA is indeed able to heterogously desensitize the CysLT 1 R.
Heterologous desensitization of CysLT 1 receptor in primary human monocytes
To be sure that dU937 cells accurately represent the spectrum of receptors expressed by monocytes/macrophages, we repeated some key experiments in monocytes. (91%, 79% and 59%, respectively, p < 0.01). fMLF and PAF used the same molecular mechanism observed in dU937 cells, i.e. unidirectional for fMLF and complete crossdesensitization for PAF (34% inhibition, data not shown). Finally, as previously observed, PAF effect was not prevented by pretreatment with 10 µM GFX (data nor shown).
Discussion
Here we report that in dU937 cells and in primary HM a series of ] i responses induced by these stimuli could be affected by a first challenge with LTD 4 (unidirectional regulation).
This was not totally unexpected, at least for fMLF, because it is known that FPR1 is resistant to this process due to the lack of PKC phosphorylation sites (35) .
Surprisingly, examining the ability of PAF-R to modulate CysLT 1 R response we found that PAF-induced desensitization could not be prevented by preincubation of cells not only with GFX, but also with inhibitors of PKA, PKG or CaMKII, alone or in combination with GFX. Thus, despite we cannot rule out the possibility that another kinase might be involved, these data point to additional mechanism(s) of transregulation besides phosphorylation (36) , either at receptor level or distal to receptor/G protein coupling. Unfortunately, despite several attempts to study groups was performed using one-way ANOVA followed by Bonferroni's Multiple
Comparison Test (**p < 0.01, vs. control, unless otherwise indicated). 
